| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |